CapsoVision, Inc. (CV) stock analysis
Healthcare · Medical Devices
From the 10-K filed 2026-03-26
How it makes money
Gastroenterologists pay for capsule endoscopes and cloud software because automated image analysis reduces the time required to diagnose GI tract abnormalities.
It derives revenue by selling diagnostic hardware and associated cloud-based diagnostic platforms. Growth depends on the adoption rate of these capsules by medical professionals and the regulatory clearance of new AI-enhanced diagnostic tools that shorten review times for clinicians.
What growth costs
It must heavily reinvest in ongoing R&D and expansive clinical trials to secure the regulatory clearances necessary for commercializing new diagnostic product generations.
To maintain and grow operations, it spends significantly on developing AI pathology tools and funding large-scale clinical studies. The company confirms that substantial capital is required for these development milestones, with high anticipated ongoing operational losses.
What could damage it
A failure to secure FDA regulatory clearance for its pipeline products would permanently impair its ability to expand revenue beyond its current limited offering.
The company's survival and growth depend entirely on the successful navigation of complex FDA 510(k) approval paths. A rejection or significant delay in the regulatory process for new products like the CapsoCam Colon prevents the company from scaling, thereby exhausting its cash reserves.
About CapsoVision, Inc.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.